Role of the Microenvironment in Mesenchymal Stem Cell-Based Strategies for Treating Human Liver Diseases
Open Access
- 16 November 2021
- journal article
- review article
- Published by Wiley in Stem Cells International
- Vol. 2021, 1-15
Abstract
Liver disease is a severe health problem that endangers human health worldwide. Mesenchymal stem cell (MSC) therapy is a novel treatment for patients with different liver diseases due to its vast expansion potential and distinctive immunomodulatory properties. Despite several preclinical trials having confirmed the considerable efficacy of MSC therapy in liver diseases, the questionable safety and efficacy still limit its application. As a precursor cell, MSCs can adjust their characteristics in response to the surrounding microenvironment. The microenvironment provides physical and chemical factors essential for stem cell survival, proliferation, and differentiation. However, the mechanisms are still not completely understood. We, therefore, summarized the mechanisms underlying the MSC immune response, especially the interaction between MSCs and the liver microenvironment, discussing how to achieve better therapeutic effects.Keywords
Funding Information
- Natural Science Foundation of Tianjin Municipality (18JCYBJC43600, 2019C03040, 21SZDSYS09, 21SZDSYS01, 19EZZDA2, 20ywb29, 2021PY083)
- Key Technology Research and Development Program of Zhejiang Province (18JCYBJC43600, 2019C03040, 21SZDSYS09, 21SZDSYS01, 19EZZDA2, 20ywb29, 2021PY083)
- Open Project Program of Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province (18JCYBJC43600, 2019C03040, 21SZDSYS09, 21SZDSYS01, 19EZZDA2, 20ywb29, 2021PY083)
- Major Research Program of Taizhou Enze Medical Center Grant (18JCYBJC43600, 2019C03040, 21SZDSYS09, 21SZDSYS01, 19EZZDA2, 20ywb29, 2021PY083)
- Program of Taizhou Science and Technology Grant (18JCYBJC43600, 2019C03040, 21SZDSYS09, 21SZDSYS01, 19EZZDA2, 20ywb29, 2021PY083)
- Medical Science and Technology Project of Zhejiang Province (18JCYBJC43600, 2019C03040, 21SZDSYS09, 21SZDSYS01, 19EZZDA2, 20ywb29, 2021PY083)
This publication has 163 references indexed in Scilit:
- In Vivo Tracking and Comparison of the Therapeutic Effects of MSCs and HSCs for Liver InjuryPLOS ONE, 2013
- Regeneration and experimental orthotopic transplantation of a bioengineered kidneyNature Medicine, 2013
- Dynamic Imaging of Marrow-Resident Granulocytes Interacting with Human Mesenchymal Stem Cells upon Systemic Lipopolysaccharide ChallengeStem Cells International, 2013
- Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosisProceedings of the National Academy of Sciences, 2012
- The Role of Mouse Mesenchymal Stem Cells in Differentiation of Naive T-Cells into Anti-Inflammatory Regulatory T-Cell or Proinflammatory Helper T-Cell 17 PopulationStem Cells and Development, 2012
- TGF-β in progression of liver diseaseCell and tissue research, 2011
- Antifibrotic Effect of MMP13-encoding Plasmid DNA Delivered Using Polyethylenimine Shielded With Hyaluronic AcidMolecular Therapy, 2011
- Mesenchymal stem cells suppress B-cell terminal differentiationExperimental Hematology, 2009
- Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse liversGut, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006